Graft derived cell-free DNA was recently reported as a non-invasive biomarker to detect graft damage or rejection after liver transplantation.There are a number of methods for quantification of Gcf-DNA,3 including quantitative-PCR, digital droplet PCR and massively parallel sequencing (next generation sequencing).Here we present Trash Can the NGS4 data and fragment size distribution of cell-free DNA in the plasma of patients with inborn errors of metabolism who underwent living-related liver transplantation.For more insights please see Analysis of fragment size distribution of cell-free DNA: a potential noninvasive marker to monitor graft damage in Floor - Nets living-related liver transplantation for inborn errors of metabolism.[1].
Keywords: Graft derived cell-free DNA, Fragment size, Living-related liver transplantation, Inborn errors of metabolism.